Skip to content

Clinical trials

Opioid-Related Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Related Disorders Country / region: United States Clear all

1,217 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20017
20026
20038
20048
200528
200620
200719
200822
200912
201020
201114
201223
201324
201419
201530
201633
201743
201851
201986
202094
2021104
202283
202384
202486
202589
202686

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed758
Recruiting176
Terminated70
Active, not recruiting65
Unknown status44
Withdrawn44
Not yet recruiting39
Enrolling by invitation17
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University97
National Institute on Drug Abuse (NIDA)73
New York State Psychiatric Institute41
Johns Hopkins University38
University of Pennsylvania30
Indivior Inc.24
NYU Langone Health23
University of California, Los Angeles21
Friends Research Institute, Inc.20
University of Chicago20

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Related Disorders1,217
Substance-Related Disorders200
Chronic Pain86
Heroin Dependence47
Pain42
Cocaine-Related Disorders38
Drug Overdose29
Alcoholism28
Stress Disorders, Post-Traumatic25
Anxiety Disorders24

Trials

Showing 51 to 75 of 1,217. Each trial links to its page on Pharma Observatory.

1,117 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.